|
Relationship Between Blood Radioimmunoreactive Beta-Endorphin and Hand Skin Temperature During The Electro-Acupuncture Induction of Ovulation
Chen Bo Ying M.D. Lecturer of Neurobiology
Institute of Acupuncture Research,
and
Yu Jin, MD., Prof of Gynecology
Obstetricus and Gynecology Hospital
Shanghai Medical University
Shanghai, People's Republic of China
(Received October 24, 1990; Accepted with revisions,
December 8, 1990)
ACUPUNCTURE & ELECTRO-THERAPEUTICS RES.,
Vol. 16, pp. 1-5,1991
Abstract:
Thirteen cycles of
anovulation menstruation in 11 cases were treated with Electro-Acupuncture (EA)
ovulation induction. In 6 of these cycles which showed ovulation, the hand skin
temperature (HST) of these patients was increased after EA treatment. In the
other 7 cycles ovulation was not induced. There were no regular changes in HST
of 5 normal subjects. The level of radioimmunoreactive beta-endorphin (rß-E)
fluctuated, and returned to the preacupunctural level in 30 min. after
withdrawal of needles in normal subjects. After EA, the level of blood rß-E in
cycles with ovulation declined or maintained the range of normal subjects. But
the level of blood rß-E and increase of HST after EA (r=-0.677, P <0.01). EA
is able to regulate the function of the hypothalamic pituitary-ovarian axis.
Since a good response is usually accompanied with the increase of HST,
monitoring HST may provide a rough but simple method for prediciting the
curative effect of EA. The role of rß-E in the mechanism of EA ovulation
induction was discussed.
 KEY WORDS: Electro-Acupuncture (EA), Hand Skin Temperature
(HST), radioimmunoreactive beta-endorphin (rß-E), ovulation, radioimmunoassay
(RIA) | 
INTRODUCTION

In
our previous work, it has been demonstrated that EA is an effectual method of
ovulation induction (1). The present work studied the relationship between the
curative effect of EA and the changes of the HST and the level of blood
beta-endorphin.
MATERIALS AND
METHODS
 Selection and Treatment of Cases
 Eleven cases of chronically
anovulatory patients including 9 cases of polycystic ovarian disease (PCO), 1
case of hypogonadotropic amenorrhea and case of oligomenorrhea were treated with
EA in 13 menstruation cycles. They were 22 to 35 years of age and their courses
of disease were 3 to 12 years. The basic body temperature (BBT) of these
patients was monophase for at least 3 months. Each patient accepted the vaginal
dropping cell examination twice or more a week. The results showed that the
eosinocyte index (EI) of 10 cases was less than 30% and the EI of 1 case was
more than 70%.
 On
the 10th day of each menstruation cycle, the patients were treated with EA.
"Guanyuan" "Zhongji," "Sanyinjiao" and both sides of "Zigong" points were
stimulated for 30 min. at 8:00 AM, OD for 3 days. The stimulation parameters
were 7-10mA and 4-5HZ with G6805 model generator. The electric current of EA was
bearable for every patient. Before and after the EA, HST was measured by a
semiconduct thermometer and blood samples were collected from the forearm vien
of patients for ß-E RIA. Five healthy woman voluteers with normal menstruation
cycle were selected as controls. They were 31 to 35 years old and the
menstruation cycle was 28 days. BBT showed change of biphase. All of them were
healthy in premenorrhea and did not take any drug one month before EA. The
stimulation points and parameters of EA were the same as above
mentioned.
 Plasma ß-Enorphin Radioimmunoassay
 The blood samples were added to
100ug/ml bacitracin for inhibiting blood aminopeptidase and centrifuged at
3,000g for 15 min. The plasma was stored at -40°C.
 The sensitive radioimmunoassay was
performed as a routine in our lab (2,3), to determine the concentration of ß-E
in the samples of plasma. Each estimative tube was added 0.1ml 1:8000 rabbit ß-E
antiserum, 0.1ml[125]I-ß-E . That is 0.03ml sheep antiserum to rabbit
gamma-globulin diluted 20-fold with RIA buffer was added to each tube, than
shaken and incubated at 0-4°C for 24 hours, and centrifuged at 3,000g for 15
min. The supernatant was poured out and the precipitate was counted for
radioactivity in Model FH 408 gamma counter. ß-E contents were quantitated
according to the standard curve which was performed at the same time with the
sample tubes. The least detected quantity of RIA was 10pg/tube.

RESULTS
 Clinical Observation
 It was adopted standards
of ovulation that BBT showed biphase and EI became cyclic variation. Six of 13
menstruation cycles treated with EA showed ovulation, while the other 7 cycles
failed to do so. No EA effect was found in normal control subjects.
 In the 13 anovulatary
cycles, increased HST occurred in 6 cycles, of which 5 cycles showed ovulation
after EA treatment. 7 cycles manifested decreased HST and only one of them
produced ovulation (Table 1). No regular change was seen in HST in normal
subjects.
 Table
l. Effect of EA Induction of Ovulation in 13 Cycles

| Changes of HST |
Ovulation |
No Ovulation |
Total |
 |
| Increased |
5* |
1 |
6 |
| Decreased |
1 |
6 |
7 |  * P<0.05 as estimated
by X[2] test
 Change of Plasrna
rß-E
 In normal
menstruation cycles the level of plasma rß-E before and after EA fluctuated and
returned to the preacupural level after 30 minutes.
 In the 13 anovulatory cycles the
level of plasma rß-E on the 10th day of the cycles was higher but not
statistically significant from that of normal subjects.
 After EA the plasma rß-E contents
of 6 cycles with ovulation either declined or maintained within the range of
normal. And the plasma level of 7 cycles that failed to show ovulation after EA
were significantly higher than those of normal subjects and 6 ovulatory cases as
estimated by t test (P<0.05), (Table 2).
 Table 2. Changes of blood
ß-E level before and after EA* (pg/ml)

| Group of cases |
No. of cycles |
Before EA |
After EA |
 |
| Ovulation |
6 |
65.59 ± 24.15 |
38.86 ±
10.11 |
| No ovulation |
7 |
65.59 ± 24.15 |
80.09 ±
22.16** |
| Normal |
5 |
38.84 ± 10.13 |
41.52 ±
6.40 |  *The
values in this table are Mean ± SE **P<0.05
 Cycles which showed increase of HST
after EA were associated with a declination of plasma rß-E Ievel but in cycles
where HST decreased, the plasma rß-E level elevated after EA. There was a
negative correlation between changes of plasma rß-E and HST as measured by rank
correlation (r=0.677, P<0.01).

Discussion
 According to our clinical practice
of using EA to cure barreness, the curative effect was related to the changes of
patients' HST. In general, provided that the body temperature was normal and the
environmental temperature was constant round 25°C, the HST may reflect the state
of sympathetic system of a patient.
 From present results, it seems that
the successful rate of EA ovulation induction was higher in patients with the
depression of sympathetic activity. In normal subject whether HST increased or
declined, no influence in ovulation was found. These results suggest that the
relationship of ovulation and HST in normal women is different from that in
anovulatory patients. Yen and his colleagues (4) first reported that enogenous
opioid peptides can inhibit pituitary pulse secreting LH. Fumiko, Akio and
Michael reported in succession that morphine, ß-E and dynorphin can also depress
LH pulse secretion (5,6,7). These substances may exert their action via
regulating the secretion of LH-RH in hypothalmus. EA can affect the central
opioid peptide level (2,8,9) thus it may regulate the function of
hypothalamic-pituitary-ovarian axis via brain endogenous opiod peptides, such as
ß-E and dynorphin etc.
 In this study 11 cycles were PCO and the blood LH level in these
cycles was marked higher than that of normal subjects. EA may promote the
release of ß-E in the brain and reduce LH-RH secretion from hypothalamus.
Therefore, the blood LH content released from the pituitary was decreased. This
might be one of the mechanisms of EA ovulation induction.
 The injection of ß-E into rat
cerebellomedullary cisterm resulted in the increase of blood epinephrine (E),
norepinephrine (NE) and dopamine (DA) levels, and there was a positive
correlation in the dose of ß-E and the levels of blood E, NE, and DA (10). The
result suggests that control ß-E may influence the activity of the sympathetic
system. Our study showed that the sympathetic activity in normal subjects was
not affected and the level of blood ß-E was relatively stable. Thus EA was not
able to influence the normal ovulatory cycles. In anovulatory patients,
especially in PCO cases, EA can depress sympathetic activity resulting in the
increase of HST and the lowering the level of blood ß-E.
 These results suggest that in
anovulatory cases the hyperactive sympathetic system can be depressed by EA and
the function of the hypothalamus-pituitary-ovarian axis can be regulated by EA
via central sympathetic system. This might be another possible mechanism of EA
ovulation induction.
 Our study also suggest that measuring HST my provide a rough but
simple method for predicting the effect of EA ovulation induction.

ACKNOWLEDGEMENT
 This report has been directed by Prof. He Lian Fang.

REFERENCES

| 1. |
Yu Jin, Zheng Hua-Mei, Chen
Bo-Yeng, Relationship of hand temperature and blood ß-endorphinelike
immunoreactive substance with electroacupuncture induction of ovulation,
Acupuncture Research vol. 11 (2), pp. 86-90, 1986. |
| 2. |
Chen Bo-Ying, Pan
Xiao-Ping, Jiang Cheng-Chuan, Chen Shang-Qun, Correlation of pain threshold and
level of ß-endoprphin like immuno-reactive substance in human CST during
electroacupuncture analgesia, Acta Physiologica Sinica vol. 36 (2), pp.
193-197, 1984. |
| 3. |
He Xiao-Ping, Chen Bo-Ying,
Zhu Jin-Ming, Cao Xiao-Ding, Change of Leu-enkephalin and ß-endorphin-like
immunoreactivity in the Hippocampus after electroconvulsive shock and
electroacupuncture, Acupuncture & Electro-Therapeutics Res., Int. J.,
vol. 14 (1), pp.131-139, 1989. |
| 4. |
Quigley, M.E., Sheeham,
K.L., Casper, R.F. and Yen, S.S.C., Evidence for an increased opioid inhibition
of luteinizing hormone secretion in hyperprolactinemic patients with pituitary
microadenoma, J. Clin. Endocrinol, Metabol, vol.50 (3), pp. 427-436,
1980. |
| 5. |
Fumiki Kinoshita,
Yoshikatsu Nakai, Hideki Katakami, Hiroo Imura, Suppressive effect of dynorphin
(1-13) on luteinizing hormone release in conscious rat, Life Sci. vol. 30
(22), pp. 1915-1919, 1982. |
| 6. |
Akio Adabori, Charles A.
Barraclough, Effect of morphine on luteinizing hormone secretion and
catecholmine turnover in the hypothalamus of estrogen-treated rats, Brain
Res. vol. 362 (2) pp. 221-226, 1986. |
| 7. |
K. Michael Orstead, Harold
G. Spics, Inhibition of hypothalamic gonadotropin releasing hormone release by
endogenous opioid peptides in the female rabbit, Neuroendocrinology, vol.
46 (1), pp. 14-23, 1987. |
| 8. |
Richard S.S., Cheng, S,
Pomeranz, B., Electroacupuncture analgesia could be mediated by least two pain
relieving endorphin and non-endorphin systems, Life Sci., vol. 25 (22),
pp. 1951-1968, 1979. |
| 9. |
Chen Bo-ying, Wang De-Ling,
Pan Xiao-Ping, Changes of opiate likesubstances (OLS) level in perfusate of
periaqueductal gray (PAG) after electroacupuncture and brain stimulation,
Acta Physiologica Sinica vol. 34 (4), pp.385-391, 1982. |
| 10. |
Glen R. Van Loon, Nathan M.
Appel, Doris Ho, ß-endorphin-induced stimulation of central sympathetic outflow:
ß-endorphin increases plasma concentration of epinephrine, norepinephrine, and
dopamine in rats, Endocrinology, vol. 109 (1), pp. 46-53, 1981.
| |
|